Annual review of pathology

Annu Rev Pathol · ISSN (e) 1553-4014 · 6 papers in corpus
review 2026
doi:10.1146/annurev-pathmechdis-032025-021500 ·PMID:42754242

Epithelial ovarian cancer is not a single disease but a group of biologically distinct malignancies that include serous (high-grade and low-grade), endometrioid, clear cell, and mucinous carcinomas, along with other rare subtypes. Integrati…

review 2022
doi:10.1146/annurev-pathol-050420-025929 ·PMID:34813354

Lysophospholipids, exemplified by lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), are produced by the metabolism and perturbation of biological membranes. Both molecules are established extracellular lipid mediators that sign…

2020
doi:10.1146/annurev-pathmechdis-012418-012917 ·PMID:31977292

The SWI/SNF (mating type SWItch/Sucrose NonFermentable) chromatin remodeling complexes interact with histones and transcription factors to modulate chromatin structure and control gene expression. These evolutionarily conserved multisubunit…

review 2019
doi:10.1146/annurev-pathmechdis-012419-032654 ·PMID:31479615

Recent molecular genetic findings on endometriosis and normal endometrium suggest a modified model in which circulating epithelial progenitor or stem cells intended to regenerate uterine endometrium after menstruation may become overreactiv…

2015
doi:10.1146/annurev-pathol-012414-040438 ·PMID:25621663

Neoplastic transformation results in a wide variety of cellular alterations that impact the growth, survival, and general behavior of affected tissue. Although genetic alterations underpin the development of neoplastic disease, epigenetic c…

2009
doi:10.1146/annurev.pathol.4.110807.092246 ·PMID:18842102

Ovarian carcinomas are a heterogeneous group of neoplasms and are traditionally subclassified based on type and degree of differentiation. Although current clinical management of ovarian carcinoma largely fails to take this heterogeneity in…